Transparency Market Research in its new report titled, “Synchronized Cardioversion Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026,” provides key insights on the Synchronized Cardioversion Market. Synchronized cardioversion is a low energy shock that uses a sensor to provide electricity that is synchronized with the highest point of the QRS complex. The shock dose used for a synchronized shock is lower than that used for defibrillation. During the delay, when the sync option is engaged on a defibrillator and the shock button pushed, the machine reads and synchronizes with the patient’s ECG rhythm.
The global synchronized cardioversion market can be segmented based on indication, end-user, and region. In terms of indication, the global market can be classified into unstable atrial fibrillation, atrial flutter, atrial tachycardia, and others. The unstable atrial fibrillation segment is expected to account for larger market share by 2026. This is because atrial fibrillation is becoming common among individuals due to various factors such as hypertension, high alcohol intake, and rise in number of people with common diseases such as diabetes and obesity.
Based on end-user, the global synchronized cardioversion market has been divided into hospitals, ambulatory surgical center, electrophysiology labs, and others. The hospitals segment is expected to account for the largest market share by 2026 due to favorable regulatory steps by governments in various countries, leading to rise in adoption of advanced procedures for diagnoses and treatment of atrial fibrillation.
In terms of region, the global synchronized cardioversion market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was a significant market for synchronized cardioversion in 2017 and the trend is expected to continue during the forecast period. North America’s dominance of the global market is attributed to increase in adoption of technologically advanced products and rise in incidence of heart diseases. According to the Centers for Disease Control and Prevention, heart diseases account for about 610,000 deaths in the U.S. each year i.e., 1 in every 4 deaths. Every year about 735,000 people in the country have a heart attack. Of these, 525,000 are a first heart attack and 210,000 happen in people who have already had a heart attack.
Prominent players operating in the global synchronized cardioversion market are ZOLL Medical Corporation, Medtronic, TZ Medical, Inc., Koninklijke Philips N.V., and ConMed Corporation.
Request a free brochure report here – http://bit.ly/2CgKhqa
About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
